0001062993-22-008356.txt : 20220322
0001062993-22-008356.hdr.sgml : 20220322
20220322184545
ACCESSION NUMBER: 0001062993-22-008356
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220318
FILED AS OF DATE: 20220322
DATE AS OF CHANGE: 20220322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Crespo Jessica
CENTRAL INDEX KEY: 0001918616
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36751
FILM NUMBER: 22761098
MAIL ADDRESS:
STREET 1: C/O OCUGEN, INC.
STREET 2: 263 GREAT VALLEY PARKWAY
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ocugen, Inc.
CENTRAL INDEX KEY: 0001372299
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 263 GREAT VALLEY PARKWAY
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 484-328-4701
MAIL ADDRESS:
STREET 1: 263 GREAT VALLEY PARKWAY
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: HISTOGENICS CORP
DATE OF NAME CHANGE: 20060810
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2022-03-18
0001372299
Ocugen, Inc.
OCGN
0001918616
Crespo Jessica
C/O OCUGEN, INC.
263 GREAT VALLEY PARKWAY
MALVERN
PA
19355
0
1
0
0
CAO/SVP, Finance
Common Stock
2022-03-18
4
A
0
22940
0
A
40440
D
Option (Right to Buy)
3.72
2022-03-18
4
A
0
84192
0
A
2032-03-18
Common Stock
84192
84192
D
Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Ocugen, Inc's (the "Company's") common stock. The restricted stock units vest annually in three equal installments commencing on March 18, 2023, subject to continued employment with the Company on the applicable vesting dates. The restricted stock units will be settled on each applicable vesting date in shares of the Company's common stock.
The option vests annually in equal installments over three years commencing on March 18, 2023, subject to continued employment with the Company on the applicable vesting dates.
Jessica Crespo
2022-03-22